In addition, TFE3-KD also decreased GFP-LC3 puncta number and inhibited GFP-LC3 degradation in RCC cell stably expressing GFP-LC3 (Figs. 6, F and G and S6D). Here, TFE3 is linked to renal cell carcinoma.